Lu Sun
- Cancer Research top 5%
- MicroRNA in disease regulation 14
- Cancer-related molecular mechanisms research 7
- Genetics top 5%
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 10
- Glycosylation and Glycoproteins Research 9
- Oncology top 5%
- Aging top 10%
-
- Pregnancy and preeclampsia studies 13
-
- Tissue Engineering and Regenerative Medicine 6
-
- Galectins and Cancer Biology 6
-
- Endoplasmic Reticulum Stress and Disease 5
- Journals
- Journal of Cellular and Molecular Medicine (6 papers)Oncology Reports (5 papers)Acta Pharmacologica Sinica (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lu Sun
124 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 130
- Cancer Research 490
- Genetics 232
- Molecular Biology 1.4k
- Oncology 545
- Aging 30
Countries citing papers authored by Lu Sun
This map shows the geographic impact of Lu Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Sun more than expected).
Fields of papers citing papers by Lu Sun
This network shows the impact of papers produced by Lu Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Sun. The network helps show where Lu Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lu Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 10 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 28 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 3 | |
| 11 | Identification and Validation of a Ferroptosis-Related Signature for Predicting Prognosis and Immune Microenvironment in Papillary Renal Cell Carcinoma | 2022 | 7 |
| 12 | 2022 | 19 | |
| 13 | 2022 | 53 | |
| 14 | 2022 | 30 | |
| 15 | 2021 | 10 | |
| 16 | 2017 | 15 | |
| 17 | 2017 | 24 | |
| 18 | 2016 | 7 | |
| 19 | 2015 | 23 | |
| 20 | 2004 | 47 |
About Lu Sun
Lu Sun is a scholar working on Obstetrics and Gynecology, Cancer Research, Geriatrics and Gerontology, Aging and Molecular Biology, having authored 127 papers that have together received 2.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (14 papers), Pregnancy and preeclampsia studies (13 papers), Epigenetics and DNA Methylation (10 papers), Glycosylation and Glycoproteins Research (9 papers), Cancer-related molecular mechanisms research (7 papers), Tissue Engineering and Regenerative Medicine (6 papers), Galectins and Cancer Biology (6 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). The work is most often cited by research in Cancer Research (490 citations), Genetics (232 citations), Molecular Biology (1.4k citations), Oncology (545 citations) and Aging (30 citations). Lu Sun has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yinkun Liu, Xiaonan Kang, Ren‐Ke Li, Shu Zhang, Khaled Machaca, Kun Guo, Chun Sun, Hai Tian, Shulin Jiang and Dongmei Gao. Their work appears in journals such as Journal of Cellular and Molecular Medicine, Oncology Reports, Acta Pharmacologica Sinica, Rejuvenation Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.